Last edition
News about " ALKEM Laboratories"
Alkem Reports Record FY26 EBITDA as Revenue Grows 13.5%; Q4 Profit Before Tax Rises 40.7 Percent
Alkem Laboratories posted its highest-ever EBITDA in FY26, driven by strong growth in domestic and international businesses, improved operating leverage, and disciplined cost management. The company also reported robust fourth-quarter performance, with revenue rising 14.6 percent and PBT before exceptional items increasing 40.7 percent YoY.
Alkem Laboratories | 29/05/2026 | By News Bureau
Alkem's Enzene Invests USD 70 Million in US Manufacturing Expansion
Enzene Biosciences, the biotechnology subsidiary of Alkem Laboratories—one of India’s leading pharmaceutical companies—has established its first US-based manufacturing facility with a USD 70 million investment.
Alkem Laboratories | 04/09/2025 | By Darshana | 522
Alkem Laboratories Signs Licensing Deal with Sonnet BioTherapeutics
Under the licensing agreement, Alkem will carry out the clinical development of 'SON-080' in India with support from Sonnet and enable global and India regulatory filings.
Alkem Laboratories | 10/10/2024 | By Aishwarya | 492
Kashmir University Hosts Lecture on Pharmaceutical Marketing Career
The placement of qualified students happens to be one of the top priorities of the university.
ALKEM Laboratories | 28/08/2023 | By Manvi | 503
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy